UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,476 | -42.3% | 52,828 | -1.4% | 0.00% | -33.3% |
| Q2 2023 | $614,015 | -52.8% | 53,579 | -17.1% | 0.00% | -57.1% |
| Q1 2023 | $1,301,950 | -20.1% | 64,645 | -10.1% | 0.01% | -56.2% |
| Q4 2022 | $1,629,860 | -3.6% | 71,895 | -20.2% | 0.02% | -20.0% |
| Q3 2022 | $1,691,000 | -3.5% | 90,134 | -4.2% | 0.02% | +5.3% |
| Q2 2022 | $1,753,000 | +66.8% | 94,065 | +61.8% | 0.02% | +111.1% |
| Q1 2022 | $1,051,000 | -15.2% | 58,136 | -2.7% | 0.01% | -10.0% |
| Q4 2021 | $1,239,000 | +80.9% | 59,734 | +179.0% | 0.01% | +66.7% |
| Q3 2021 | $685,000 | +5.9% | 21,411 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $647,000 | – | 21,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |